| イタリア | トルコ | オーストリア | |
| 膝関節鏡視下手術 | から $4,500 | から $1,800 | から $4,500 |
| 膝の幹細胞治療 | から $8,000 | から $3,500 | から $12,000 |
| 変形性関節症幹細胞治療 | から $9,000 | から $6,000 | から $12,000 |
| 人工膝関節置換術 | から $14,000 | から $6,500 | から $20,000 |
| マコプラスティ | から $18,000 | から $6,900 | から $28,000 |
Bookimedは変形性膝関節症治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。変形性膝関節症治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。変形性膝関節症治療の旅路でお一人になることはありません。
Dr. Luigi Massimo Zagra is the Head of Hip Surgery at IRCCS Istituto Ortopedico Galeazzi in Milan. He has performed over 5,000 major orthopedic operations. Dr. Zagra focuses on complex hip primary and revision surgeries. He is a visiting professor at the University of Milan.
Dr. Roberto Danchise is an orthopedic surgeon at IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan. He performed the first meniscus transplant in Italy. Dr. Danchise has completed 16,000+ arthroscopic procedures. He has also performed over 2,100 knee replacements. He specializes in sports injuries, joint diseases, and traumatology.
Dr. Raul Zini is an orthopedic surgeon at Maria Cecilia Hospital in Italy. He has performed about 15,000 operations throughout his career. Dr. Zini is a specialist in hip, knee, and shoulder arthroscopy. Many professional international athletes seek his expertise for sports-related injuries.
Evidence-based treatment for osteoarthritis in Italy follows a tiered approach from conservative therapies to advanced surgery. International patients access specialized centers in Milan and Rome for robotic-assisted joint replacement and minimally invasive arthroscopy. Italian clinical guidelines prioritize weight management, hydrokinesitherapy, and specialized balneotherapy alongside pharmacological management.
Bookimed Expert Insight: IRCCS OSPEDALE GALEAZZI - SANT'AMBROGIO is a critical destination for complex cases. It handles 75% of all revision orthopedic surgeries in Italy. This high concentration of complex cases suggests that even failed previous surgeries can be addressed here. Dr. Roberto Danchise and Prof. Luigi Massimo Zagra have performed over 5,000 to 16,000 procedures each. This massive surgical volume correlates with the facility's high patient satisfaction ratings.
Patient Consensus: Patients note that while early-stage therapies like physiotherapy are effective, wait times for surgery can reach 18 months. Many participants emphasize maintaining a BMI under 30 to ensure the best possible surgical outcomes.
Milan, Rome, and Bologna are Italy's premier hubs for osteoarthritis care. IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan leads the country. It handles 75% of Italy's revision surgeries. San Raffaele and Maria Cecilia Hospital also offer advanced regenerative therapies like stem cells and PRP.
Bookimed Expert Insight: Milan centers offer a unique concentration of high-volume expertise. Galeazzi - Sant'Ambrogio alone treats 343,500 patients annually. This volume is critical for complex cases. It explains why they manage 75% of Italy's revision surgeries. Doctors like Dr. Roberto Danchise at this facility have performed 2,100+ knee replacements. This depth of experience typically leads to better long-term implant outcomes.
Patient Consensus: Patients note that private clinics in Milan provide much faster access to biologics than public facilities. They emphasize that while public centers have long waitlists, private regenerative treatments like PRP often provide immediate pain relief.
Stem cell and PRP therapies for osteoarthritis are widely available across Italy at specialized orthopedic research institutes and private hospitals. Licensed facilities in Milan and Rome offer autologous stem cell transplants and platelet-rich plasma injections. These regenerative procedures follow strict health protocols within European government-approved centers.
Bookimed Expert Insight: Milan serves as the primary hub for regenerative orthopedics. IRCCS Ospedale Galeazzi - Sant'Ambrogio manages 75% of Italy's revision orthopedic surgeries. This high volume suggests that patients seeking stem cell therapy benefit from surgeons who handle the most complex reconstructive cases. San Raffaele adds further depth by managing 300,000 patients annually in one of Europe's largest research environments.
Patient Consensus: Patients value the balance of premium care and clinical rigor found in Milanese clinics. Many note that the high standards of private facilities provide peace of mind during recovery.
Modern joint implants in Italy typically last 15 to 25 years. Longevity depends on patient activity levels and surgical precision. Italian centers utilize 3D additive manufacturing and robotic-assisted techniques to improve implant stability. Advanced biomaterials like highly cross-linked polyethylene and ceramics further reduce mechanical wear and friction.
Bookimed Expert Insight: Italian centers like IRCCS Ospedale Galeazzi - Sant'Ambrogio handle 75% of Italy's revision surgeries. This high volume creates a unique cycle where surgeons become experts at identifying why implants fail. They often select specific brands like Zimmer Biomet to prevent early loosening. Choosing a center focused on revisions typically ensures a more durable primary replacement.
Patient Consensus: Patients note that following strict physiotherapy and low-impact lifestyles helps extend joint life. Many emphasize requesting ceramic-on-plastic bearings to minimize long-term wear debris.
Italian orthopaedic specialists utilize multimodal analgesia if standard NSAIDs prove insufficient. They combine acetaminophen with medications like gabapentinoids for nerve pain. Interventional techniques such as ultrasound-guided nerve blocks or epidural analgesia provide extended relief. Physicians also prioritize non-pharmacological methods like cryotherapy and TENS to manage postoperative discomfort.
Bookimed Expert Insight: Italian IRCCS research hospitals prioritize specialized surgical experience to minimize recovery pain. Dr. Roberto Danchise at IRCCS Ospedale Galeazzi - Sant'Ambrogio has performed 2,100+ knee replacements. This high volume often results in more efficient procedures and precise implant placement. Better surgical precision naturally reduces the need for heavy postoperative medication escalation.
Patient Consensus: Patients note that documenting daily pain levels helps secure faster access to nerve blocks. Many emphasize that religious use of ice and TENS machines effectively bridges the gap when medication doses wear off.
Italian specialists delay surgery by using lifestyle modifications to reverse metabolic triggers and reduce joint inflammation. Structured programs combining the Mediterranean diet and low-impact exercise lower mechanical pressure on joints. These interventions help patients stabilize their condition and reach a safer biological age before intervention.
Bookimed Expert Insight: Italian orthopedic centers prioritize high-volume expertise, with IRCCS Ospedale Galeazzi - Sant'Ambrogio performing 75% of Italy's revision surgeries. This centralisation means leading surgeons like Dr. Roberto Danchise, who has performed over 2,100 knee replacements, often recommend delaying primary surgery with lifestyle changes. They know that expert-led conservative management can postpone the need for complex revisions later in life.
Patient Consensus: Patients note that losing 15 kg through a specialized diet and aqua gym can delay knee replacement by seven years. Many emphasize that adding supplements like turmeric and curcumin under specialist guidance significantly halves pain without requiring opioids.
Approximately 77% of osteoarthritis patients in Italy report high weather sensitivity. High humidity and cold temperatures often increase synovial fluid thickness and joint stiffness. Italian specialists manage these fluctuations using thermal balneotherapy and the Mediterranean diet to reduce inflammation effectively.
Bookimed Expert Insight: Italian orthopedic care shows a unique concentration of expertise in Milan. IRCCS Galeazzi performs over 5,000 operations annually and handles the vast majority of complex revision cases in the country. This high volume suggests that patients with weather-aggravated symptoms who eventually require surgery benefit from surgeons like Dr. Roberto Danchise, who have managed thousands of similar cases.
Patient Consensus: Patients note it is important to prepare for damp winter months when joint pain often peaks. They frequently suggest using heat packs to manage stiffness during the cold seasons in Italy.
Recommended hospitals for treating osteoarthritis in Italy include IRCCS Ospedale Galeazzi - Sant'Ambrogio and Maria Cecilia Hospital. These JCI or ISO-certified facilities specialise in hip and knee replacements. They offer techniques like MAKOplasty and stem cell therapy. Surgeons here often perform over 2,000 joint procedures.
Bookimed Expert Insight: Many centres offer joint surgery. However, specialist experience in Italy is exceptionally concentrated. Dr Luigi Massimo Zagra and Dr Roberto Danchise have performed over 21,000 procedures combined. This high volume often leads to better results in complex revision cases. This is especially true where previous implants have failed. Patients should prioritise these high-capacity research hospitals (IRCCS) for the best surgical outcomes.
Patient Consensus: Patients note it is vital to choose high-volume centres in Italy. They recommend centres with dedicated orthopaedic wards. They also emphasise confirming that coordinated physiotherapy and English-speaking support are arranged before travelling.
Regenerative medicine for osteoarthritis is widely available in Italian orthopaedic centres. Specialists use platelet-rich plasma (PRP) and stem cell therapies, such as adipose-derived cells, to treat joint degeneration. These treatments are offered at JCI-accredited facilities in Milan, Rome, and Bologna.
Bookimed Expert Insight: Italy's orthopaedic sector is highly centralised. Milan's Galeazzi-Sant'Ambrogio Hospital alone performs 75% of all revision orthopaedic surgeries in the country. This concentration of complex cases gives surgeons there high levels of experience. For example, Dr Roberto Danchise has performed over 15,000 procedures. Patients often benefit from this high-volume expertise. Specialists frequently combine biological therapies with arthroscopic methods to delay or avoid full joint replacements.
Patient Consensus: Patients find that regenerative treatments in Italy are primarily available through private clinics. Public options for these therapies are limited. Experience shows it is vital to clarify which cells a procedure uses. Terms for bone marrow, fat-derived cells, or PRP can vary between facilities.
International patients may travel to Italy for osteoarthritis treatment through private healthcare pathways. Non-residents must use private hospitals or secure a medical visa for access. Australia's reciprocal agreement covers only urgent care. Specialised centres in Milan and Rome offer robotic surgery and stem cell therapies.
Bookimed Expert Insight: Italy's orthopaedic strength lies in high-volume research hospitals rather than small clinics. Galeazzi-Sant Ambrogio serves over 340,000 patients annually. It leads the country in complex revision surgeries. For Australians, choosing these IRCCS-accredited research centres provides access to doctors like Prof. Luigi Massimo Zagra. He holds leadership roles in major European hip societies.
Patient Consensus: Patients in Italy suggest confirming English-language discharge plans before surgery. This helps Australian GPs manage recovery. Many note that non-surgical treatments like stem cell therapy are often easier to organise than major joint replacements.
Typical waiting times in Italy vary significantly between the public and private sectors. Public system patients generally wait 10 months for a hip replacement. They wait around 7 months for a knee replacement. Private facilities, such as IRCCS Ospedale Galeazzi - Sant'Ambrogio, offer much faster access.
Bookimed Expert Insight: Italian orthopaedic care is highly centralised in Milan. Research hospitals like IRCCS Ospedale Galeazzi - Sant'Ambrogio perform 5,000 operations annually. Choosing a facility with IRCCS accreditation provides access to high-volume centres. This helps because specialised surgeons like Prof. Luigi Massimo Zagra or Dr Roberto Danchise have performed over 5,000 to 16,000 procedures. Their high volume often leads to better outcomes for complex osteoarthritis cases.
Patient Consensus: Patients note that the longest delays often occur during initial referral and imaging stages. They suggest confirming whether a booking is for the private or public track. This choice dictates if surgery happens in weeks or many months.